Back to MORGAN STANLEY MORGAN STANLEY

LYELLYEL
5 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in LYELL IMMUNOPHARMA INC

MORGAN STANLEY holds 37,050 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $520,553 as of 2026-Q2. The position was decreased (-34.0% shares).

Current Value

$520,553

Current Shares

37,050

Total Value Change

+$293,383

Total Shares Change

+11,352

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
37,050
-34.0%
$520,5530.0%$14.05
0
2026-Q1
Increased
56,151
+30.7%
$1.1M0.0%$23.33
32
2025-Q4
Increased
42,949
+16.0%
$1.3M0.0%$31.59
29
2025-Q3
Increased
37,020
+44.1%
$601,2040.0%$14.97
22
2025-Q2
New
25,698
-
$227,1700.0%$8.94
35

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used